Is this you? Create Your Porfile
Avatar

Hans-Peter Schubert

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Hans-Peter Schubert is active.

Explore More

Publication

Featured researches published by Hans-Peter Schubert.

Archive | 1992

Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas

Hans-Peter Schubert; John J. Grome; Barbara Dr. Kittner; Karl Rudolphi; Ulrich Dr Gebert

Archive | 1998

Combination preparation for use in dementia

Hans-Peter Schubert; Hildegard Nimmesgern; Karl Rudolphi

Archive | 1992

Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata

Hans-Peter Schubert; John J. Grome; Barbara Dr. Kittner; Karl Dr. Rudolphi; Ulrich Dr Gebert

Archive | 2005

PREPARADO COMBINADO PARA UTILIZACAO NA DEMENCIA, CONTENDO PELO MENOS UM COMPOSTO QUE APRESENTA UM EFEITO DE INIBICAO DA ESTERASE DA ACETILCOLINA OU UM EFEITO MUSCARINICO E UM COMPOSTO QUE ELEVA O NIVEL ENDOGENO EXTRACELULAR DA ADENOSINA

Hans-Peter Schubert; Hildegard Nimmesgern; Karl Rudolphi

Archive | 1998

Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks

Hans-Peter Schubert; Hildegard Nimmesgern; Karl Rudolphi

Archive | 1998

Kombinationspräparat zur Anwendung bei Demenz, enthaltend mindestens eine Verbindung die eine Acetylcholinesterase-Hemmwirkung oder muskarinerge Wirkung zeigt und eine Verbindung die den endogenen extrazellulären Adenosinspiegel erhöht

Hildegard Nimmesgern; Karl Dr. Rudolphi; Hans-Peter Schubert

Archive | 1998

Combinatory compositions for the treatment of dementia containing at least a compound having acetylcholinesterase-inhibitory or muscarinic activity and a compound that enhances the endogenous extracellular adenosine levels

Hildegard Nimmesgern; Karl Dr. Rudolphi; Hans-Peter Schubert

Archive | 1998

Kombinationspræparat til anvendelse ved demens

Karl Rudolphi; Hildegard Nimmesgern; Hans-Peter Schubert

Archive | 1998

Compositions combinées pour le traitement de la démence contenant au moins un produit à effet inhibiteur de acetylcholinestérase ou muscarinique et un produit qui accroit le niveau d'adénosine endogène extracellular

Hildegard Nimmesgern; Karl Dr. Rudolphi; Hans-Peter Schubert

Archive | 1998

PREPARADO DE COMBINACION PARA EL TRATAMIENTO DE LA DEMENCIA, QUE CONTIENE AL MENOS UN COMPUESTO QUE TIENE ACTIVIDAD INHIBIDORA DE LA ACETILCOLINESTERASA O MUSCARINICA Y UN COMPUESTO QUE AUMENTA LOS NIVELES DE ADENOSINA ENDOGENA EXTRACELULAR.

Hildegard Nimmesgern; Karl Dr. Rudolphi; Hans-Peter Schubert

Explore More

Collaboration

Dive into the Hans-Peter Schubert's collaboration.

Top Co-Authors
Avatar

Hildegard Nimmesgern

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Karl Rudolphi

Max Planck Society

View shared research outputs
Top Co-Authors
Avatar

Karl Dr. Rudolphi

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

John J. Grome

University of Glasgow

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge